Ipamorelin is a common synthetic peptide used in the world today, and it has the ability to bind selectively to a growth hormone receptor known as secretagogue.
Ipamorelin and Its Top Uses in Medicine
Ipamorelin is a commonly used synthetic peptides, and it has the ability to bind selectively to a growth hormone receptor known as secretagogue. It contains two artificial amino acids which distinguishes it from the normal peptide growth hormone releasing protein, which forms its basis.
From various clinical studies, it has been discovered that ipamorelin has a potency and an efficacy in releasing growth hormone in a similar manner to GHRP-6. Due to these and many other characteristics, Ipamorelin is currently being used in a wide range of scientific studies, and here are some the areas where it is currently being applied:
Appetite and gastrointestinal system
As a ghrelin mimetic, ipamorelin increases appetite and motility along the gut. A study using rats as a model of postoperative decreases showed that repeated doses of ipamorelin reduced considerably the rate of food intake, the amount of fecal matter, and the overall body weight during the first 48 hours after an experimental surgery was performed.
Ipamorelin and diabetes
It has been found that ghrelin has the ability to increase the amount of pancreatic insulin produced by both diabetic and normal rats. It implies that ipamorelin will also have similar effects. It follows, then, that the mechanism ipamorelin uses to stimulate the release of insulin is the same mechanism used by ghrelin in diabetic rats.
Ipamorelin and interactions
It has been discovered that growth hormones have the ability to hinder the negative effects associated with repeated steroid treatments on the balance of nitrogen in the body. These effects may increase the chances of liver damage. A study involving rats found that using ipamorelin reduced lowered prednisolone-mediated urea synthesis, but this happened at a lower level compared to the effects of growth hormone.